- Home
- VSTM vs URG Comparison
VSTM vs URG Comparison
Compare VSTM & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- URG
- Stock Information
- Founded
- VSTM 2010
- URG 2004
- Country
- VSTM United States
- URG United States
- Employees
- VSTM N/A
- URG N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- URG Precious Metals
- Sector
- VSTM Health Care
- URG Basic Materials
- Exchange
- VSTM Nasdaq
- URG Nasdaq
- Market Cap
- VSTM 598.2M
- URG 565.5M
- IPO Year
- VSTM 2012
- URG N/A
- Fundamental
- Price
- VSTM $9.54
- URG $1.51
- Analyst Decision
- VSTM Strong Buy
- URG Strong Buy
- Analyst Count
- VSTM 9
- URG 3
- Target Price
- VSTM $13.38
- URG $2.63
- AVG Volume (30 Days)
- VSTM 2.6M
- URG 6.9M
- Earning Date
- VSTM 11-05-2025
- URG 11-05-2025
- Dividend Yield
- VSTM N/A
- URG N/A
- EPS Growth
- VSTM N/A
- URG N/A
- EPS
- VSTM N/A
- URG N/A
- Revenue
- VSTM $2,137,000.00
- URG $39,488,000.00
- Revenue This Year
- VSTM $88.50
- URG N/A
- Revenue Next Year
- VSTM $398.66
- URG $232.02
- P/E Ratio
- VSTM N/A
- URG N/A
- Revenue Growth
- VSTM N/A
- URG 149.20
- 52 Week Low
- VSTM $2.54
- URG $0.55
- 52 Week High
- VSTM $11.25
- URG $1.62
- Technical
- Relative Strength Index (RSI)
- VSTM 57.41
- URG 59.60
- Support Level
- VSTM $9.10
- URG $1.47
- Resistance Level
- VSTM $10.06
- URG $1.60
- Average True Range (ATR)
- VSTM 0.69
- URG 0.08
- MACD
- VSTM -0.17
- URG -0.00
- Stochastic Oscillator
- VSTM 25.33
- URG 60.34
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.